Gastrointestinal Endoscopy
Volume 71, Issue 4 , Pages 697-703, April 2010

Prevalence and predictors of recurrent neoplasia after ablation of Barrett's esophagus

Current affiliations: Barrett's Esophagus Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA

Received 28 April 2009; accepted 28 August 2009. published online 04 December 2009.

Rochester, Minnesota, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 DISCLOSURE: Supported by NIH grants R01 CA111603-01A1 and R01CA097048 to K.K. Wang and R03CA135991-01 to G.A. Prasad. All other authors disclosed no financial relationship relevant to this publication.

PII: S0016-5107(09)02431-6

doi:10.1016/j.gie.2009.08.031

Gastrointestinal Endoscopy
Volume 71, Issue 4 , Pages 697-703, April 2010